標題: Titlebook: Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases; Dinesh Kumar Chellappan,Kavita Pabreja,Md. Faiyazu Boo [打印本頁] 作者: FAULT 時間: 2025-3-21 18:37
書目名稱Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases影響因子(影響力)
書目名稱Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases影響因子(影響力)學科排名
書目名稱Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases網(wǎng)絡(luò)公開度
書目名稱Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases網(wǎng)絡(luò)公開度學科排名
書目名稱Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases被引頻次
書目名稱Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases被引頻次學科排名
書目名稱Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases年度引用
書目名稱Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases年度引用學科排名
書目名稱Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases讀者反饋
書目名稱Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases讀者反饋學科排名
作者: BULLY 時間: 2025-3-21 20:37 作者: 詞匯記憶方法 時間: 2025-3-22 03:59
Inflammatory Respiratory Diseases: Correlation Between Lung Cancer and COVID-19,tive, evolutionary-based life, but as an Earthly vitalism that can and does proceed otherwise via the play of order and disorder, intensity and extension? Following some comments on the recent uptick in the work expected of geologic imaginaries and geologic materials in Anthropocene debates, this ch作者: 使厭惡 時間: 2025-3-22 06:22
Advancements in Translational Respiratory Research Using Nanotechnology, collects perspectives from a wide cross-section of disciplines to explain what drives gerrymandering, why it can be hard to stamp out, and how we might go about fixing it. With topics ranging from the Voting Rights Act to Markov chains to the geography of communities, this book serves as a 21st cen作者: Vulnerary 時間: 2025-3-22 10:10
Nanoparticles in Chronic Respiratory Diseases,l system regarding its political control role. Although during the bailout period to Portugal (May 2011–May 2014), the main meetings with the Troika delegation took place outside the Parliament, at the headquarters of the Government and of the Socialist Party (then the main opposition party), Parlia作者: assent 時間: 2025-3-22 13:45
Applications of Nanotechnology in Pulmonary Disease Diagnosis,s. As the demographic structure and the composition of households have changed, long-term care services for the aged are becoming an imminent welfare state policy issue across advanced democracies. The increase of the ‘older old-aged’ (i.e., 75 years old and over) population creates the need for soc作者: 死亡率 時間: 2025-3-22 18:53 作者: 撫育 時間: 2025-3-22 22:15 作者: LIMIT 時間: 2025-3-23 04:58
Microparticles, Microspheres, and Microemulsions in Respiratory Diseases,essments of many other 20th century political leaders. Its aim is to enrich our knowledge of an important dimension of global politics: charismatic leadership. The central role of political leaders in shaping the behavior of states has been universally recognized since the political systems of antiq作者: Mosaic 時間: 2025-3-23 05:42
Advanced Drug Delivery Systems Targeting the Immune System at Cellular Level in Chronic Respiratoryhe high level of competition to gain a slot in politicians’ diaries. This chapter therefore sets out to provide a greater understanding of basic disaster concepts, ranging from early research to the cascading effects of disasters, the role of social capital and the bureaucracies that govern response作者: 忘川河 時間: 2025-3-23 12:34 作者: 不幸的人 時間: 2025-3-23 16:26
Polymeric and Inorganic Nanoparticles Targeting Chronic Respiratory Diseases,among the various branches of the central government. Rather than being concentrated in one level, power was divided between the federal government at the central level and state governments at the subcentral level. Moreover, at the federal level, power was divided among the three branches of govern作者: cravat 時間: 2025-3-23 20:49 作者: Pulmonary-Veins 時間: 2025-3-23 23:13
https://doi.org/10.1007/978-981-16-4392-7Biomarkers; Drug Delivery systems; Inflammation; Nanoparticles; Oxidative stress; Respiratory diseases作者: 掙扎 時間: 2025-3-24 05:01
978-981-16-4394-1The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapor作者: 慢慢流出 時間: 2025-3-24 06:39
Dinesh Kumar Chellappan,Kavita Pabreja,Md. FaiyazuDiscusses perspectives and challenges in management and diagnosis of respiratory diseases.Provides insights into drug delivery systems in pulmonary diseases.Includes diagnosis and treatment strategies作者: Fecundity 時間: 2025-3-24 12:13 作者: aesthetician 時間: 2025-3-24 18:17
Auswertung von mehrdimensionalen Daten, mortality due to respiratory diseases like asthma, chronic obstructive pulmonary diseases, interstitial lung diseases, cystic fibrosis (CF), respiratory infections and lung cancers impose enormous socio-economic burdens. Despite the significant improvement in understanding the mechanisms of these d作者: GRACE 時間: 2025-3-24 21:44 作者: LATHE 時間: 2025-3-25 01:17 作者: ARM 時間: 2025-3-25 03:39
Auswertung von mehrdimensionalen Daten,tory diseases arises mainly from vulnerabilities including air pollution, occupational risks, tobacco smoking, microbial infection, and allergens. The deliberated efforts in developing therapeutics for containing these disorders led to the identification of diverse pharmacophores and chemical moieti作者: 僵硬 時間: 2025-3-25 08:05
,Konzentrations- und Disparit?tsmessung,nature and structural diversity, various phytochemicals are gaining research interest for the discovery and development of effective therapeutic agents for various diseases, including lung diseases. Bioavailability and metabolism have been the main limiting factors for the effective use of these phy作者: 情愛 時間: 2025-3-25 13:45
Auswertung von eindimensionalen Daten, these, the CLDs are expected to be among the top four causes of death across the globe. The conventional?management for these diseases includes strategies manipulating miRNA, siRNA, shRNA and drugs used in the treatment..As these require longer, sometimes lifelong treatment, there is an urgent need作者: Inordinate 時間: 2025-3-25 19:44
Auswertung von mehrdimensionalen Daten,rden on the aging population and emerging as a major health concern worldwide. Various bronchodilators, anti-inflammatory drugs, antibiotics, and gene therapies have been applied to reduce and treat these respiratory diseases. Furthermore, the limitations of conventional approaches, such as low perm作者: Narcissist 時間: 2025-3-25 23:49
,Konzentrations- und Disparit?tsmessung,ilic and lipophobic macromolecules to target specific sites of action. These particles have an exclusive property to encapsulate lipophilic and lipophobic macromolecules in the nanostructure. The key benefits of nanoparticle-based drug delivery to the pulmonary tissues are the unique pharmacokinetic作者: rectocele 時間: 2025-3-26 01:39 作者: GRIN 時間: 2025-3-26 06:54
,Konzentrations- und Disparit?tsmessung,mifications of these pulmonary diseases are evident in terms of impaired work productivity and quality of life mitigations in the daily healthcare activities. Among the pulmonary diseases, chronic obstructive pulmonary disease (COPD), occupational lung diseases (such as silicosis), asthma, lung canc作者: 禍害隱伏 時間: 2025-3-26 09:11
Auswertung von eindimensionalen Daten,every year. Various researches have been performed to identify the cause and cure, trying to reduce the mortality rate for lung diseases. Likewise, nanotechnology-based methods and materials have opened a new way in the management of pulmonary diseases. The nanoparticle-based materials can easily id作者: 腐爛 時間: 2025-3-26 16:25
https://doi.org/10.1007/978-3-662-41295-4pulation due to the genetic polymorphism and associated environmental factors. The increase in the incidence of these ailments and shortfalls associated with the current treatment regimen results in poor disease management. Thus, there is a need of a novel drug delivery approach which could offer a 作者: 有惡臭 時間: 2025-3-26 19:27
Beschreibung des Augenspiegels,ery year. The current lung disease treatment therapies are comprised of chemical drugs, peptides, genetic molecules (e.g., siRNA, miRNA, shRNA), and antibodies. The current therapies provide only symptomatic relief instead of complete recovery from these chronic diseases. Moreover, the systemic deli作者: ANN 時間: 2025-3-26 23:42
https://doi.org/10.1007/978-3-476-03136-5g it an optimal route for non-invasive administration of pharmacotherapeutics. Localized delivery not only demonstrates remarkable efficacy in the treatment of respiratory diseases, but also lessens the associated systemic toxicity. Conversely, systemic drug delivery can be accomplished by targeting作者: 虛弱的神經(jīng) 時間: 2025-3-27 02:56 作者: craven 時間: 2025-3-27 07:59 作者: Callus 時間: 2025-3-27 09:41 作者: 議程 時間: 2025-3-27 14:40
https://doi.org/10.1007/978-94-015-3328-7seases. These include asthma, cystic fibrosis, and lung cancer, in which current conventional therapies are insufficient in controlling the progression of these diseases, leading to negative consequences such as impaired work productivity and poor quality of life. These have prompted medical researc作者: 自作多情 時間: 2025-3-27 21:43 作者: Innocence 時間: 2025-3-28 01:40
Auswertung von mehrdimensionalen Daten,rging need for suitable, effective and patient-complaint pharmaceuticals. In this chapter, we provide an overview of the burden of respiratory diseases, current treatments and limitations; a brief outline of chronic lung diseases and their pathogenic mechanisms; and the need for the development of n作者: 起草 時間: 2025-3-28 03:57
https://doi.org/10.1007/b138006at a lower dose, with enhanced bioavailability and increased patient compliance. This chapter summarizes the different types of nanoparticles and the current inventive attempts to use nanoparticles as new drug carriers for the successful management of chronic respiratory diseases.作者: 不真 時間: 2025-3-28 09:31
Auswertung von mehrdimensionalen Daten,ted drug delivery and the controlled release of therapeutic drugs. The intention of this book chapter is to review the conventional therapies used for treating respiratory diseases and the available vesicular systems that can be employed for treating respiratory diseases.作者: GET 時間: 2025-3-28 12:55
,Konzentrations- und Disparit?tsmessung,riumph the biological and other pulmonary barriers leading to the enhancement not only in the therapeutic performance but also in the diagnosis. It is documented that although the extent of uptake of nanoparticle by pulmonary tissues is primarily affected by the physicochemical characteristics of na作者: 講個故事逗他 時間: 2025-3-28 17:12
Beschreibung des Augenspiegels,the readers an understanding of the challenges in pulmonary drug delivery and the need of lipid nanocarriers in pulmonary delivery. Additionally, this book chapter also focuses on the bright future and applications of solid lipid nanocarriers-based drug delivery systems for pulmonary targeting.作者: occult 時間: 2025-3-28 19:17
https://doi.org/10.1007/978-3-476-03136-5g delivery systems such as microparticles, microspheres, and microemulsions in the treatment of the prevalent respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), infections, and lung cancer. Although the conventional drugs have conferred proven therapeutic efficacy in 作者: flavonoids 時間: 2025-3-29 00:20 作者: 聯(lián)合 時間: 2025-3-29 04:17
https://doi.org/10.1007/978-94-015-3328-7en extensively studied for their potential as carriers for chemical and biological drugs. These nanosized drug carriers enable the delivery of therapeutic moieties?with improved physiochemical properties, bioavailability, and biocompatibility. In this chapter, we will address the perspectives for th作者: 散布 時間: 2025-3-29 09:38 作者: Hearten 時間: 2025-3-29 12:42 作者: affect 時間: 2025-3-29 15:46
Phytochemicals and their Nanoformulations Targeted for Pulmonary Diseases,978-3-030-18630-2作者: 過份艷麗 時間: 2025-3-29 21:38
Nanocarriers: An Advanced and Highly Effective Approach for Targeting Chronic Lung Diseases,作者: lobster 時間: 2025-3-30 02:53
Vesicular Drug Delivery Systems in Respiratory Diseases,978-1-349-10396-6作者: LEVER 時間: 2025-3-30 06:47
Recent Trends in Nanomedicine for Diagnosis and Treatment of Pulmonary Diseases,978-94-015-8603-0作者: 阻擋 時間: 2025-3-30 08:35 作者: Ataxia 時間: 2025-3-30 16:14 作者: Preamble 時間: 2025-3-30 18:00 作者: 讓你明白 時間: 2025-3-30 22:04
Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases978-981-16-4392-7作者: LARK 時間: 2025-3-31 01:57
An Introduction to Respiratory Diseases and an Emerging Need for Efficient Drug Delivery Systems,as the first great victory for a Europe-wide mobilisation of public opinion. A Danish government spokesperson declared that: ‘People have been speaking with their hearts and not their brain on this. Ecology is now the ultimate political correctness. Today’s consumers have been brought up to think very differently to their parents.作者: 發(fā)現(xiàn) 時間: 2025-3-31 07:26 作者: 褲子 時間: 2025-3-31 11:25
Targeted Micellar Systems for Pulmonary Disease Intervention,ic support for the MDC, and against all trends in the region, Mugabe managed to strengthen his grip. In fact, while his unpopularity at home peaked in the first few years of the millennium, by 2004 Mugabe’s skillful intermestic policy making reversed some of his most significant losses.作者: Neutropenia 時間: 2025-3-31 16:43 作者: ALTER 時間: 2025-3-31 17:39 作者: MAUVE 時間: 2025-3-31 22:29 作者: 下垂 時間: 2025-4-1 05:36
Applications of Nanotechnology in Pulmonary Disease Diagnosis, funded elderly care services is also considerably varied across advanced industrialized democracies. How can we explain this variety of policy responses to socio-demographic transformation? This is the research question this study tackles.作者: 難理解 時間: 2025-4-1 07:25
Advanced Drug Delivery Systems Targeting the Immune System at Cellular Level in Chronic Respiratoryto the relationships between elected officials, emergency managers and those affected by disasters. As our book is more practically than theoretically oriented, we leave the debate around the definition of terminology to other scholars for more considered discussion and in-depth exploration.作者: 性行為放縱者 時間: 2025-4-1 14:03
Polymeric and Inorganic Nanoparticles Targeting Chronic Respiratory Diseases,between representatives in the various, separated institutions. In this respect, the US leadership environment more closely resembles its German counterpart than either its British or French equivalent.作者: 聽寫 時間: 2025-4-1 16:41 作者: 緯度 時間: 2025-4-1 20:34
Strategies for Enhanced Drug Targeting to Inflamed Lungs: Novel Perspectives,onsolidate the gains in applying indigenous institutional rules, laws, and practices as a launch-pad for effective environmental protection invariably finds support in international environmental law principles.
